Greenspace Herbs has formally entered the U.S. market with the appointment of veteran supplement executive Greg Arabatzis as chief business officer, USA, underscoring the company’s intent to commercialize its Quantum Ayurveda platform at scale.

The expansion is anchored by the establishment of a warehouse and operational office in New Jersey, positioning the company within one of the most active dietary supplement corridors in North America.

Leadership with Market Depth

Arabatzis has over two decades of experience in brand building, ingredient commercialization, and channel development within the U.S. nutraceutical industry. Known for helping scale science-backed wellness brands into multimillion-dollar enterprises, he is expected to guide Greenspace’s regulatory positioning, strategic partnerships, and national market rollout.

“The U.S. market rewards clinically substantiated innovation,” Arabatzis said. “Quantum Ayurveda stands out because it is not theoretical; it is supported by published scientific data. Our focus now is structured commercialization, education, and partnership development.”

Clinical Validation

Quantum Ayurveda has undergone clinical validation, with research findings published in peer-reviewed scientific journals. The platform integrates traditional Ayurvedic botanicals with frequency-based technological enhancement, aiming to optimize biological response at the cellular level.

Clinical observations indicate improved response kinetics and efficiency at lower dosages of key botanicals, including curcumin, bacopa, ashwagandha, and berberine. According to the company, outcomes demonstrate measurable effects at nearly one-third of conventional dosing levels, with accelerated response timelines.

This data-backed positioning differentiates Quantum Ayurveda in a U.S. market increasingly demanding peer-reviewed evidence and functional performance validation.

From Asia to America

Quantum Ayurveda has already been launched in India and key Asian markets as part of Greenspace’s broader expansion strategy. The company reported strong early adoption across branded ingredient partnerships and finished product collaborations in those regions.

Now, with its U.S. infrastructure is operational, Greenspace intends to localize its innovation model.

“Quantum Ayurveda has been clinically established and commercially introduced across USA, India and Asia,” said Shafiulla Hirehal Nuruddin, founder and managing director, Greenspace Herbs. “With localized operations and leadership in the U.S., we aim to integrate research, regulatory alignment, and commercial partnerships within the U.S. ecosystem.”

Local Investment

Greenspace plans to invest in establishing fully localized Quantum Technology Frequency Labs in the U.S. These facilities are expected to support:

• Clinical collaborations and validation studies
• Ingredient customization for U.S. formulations
• Partner co-development programs
• Scalable manufacturing integration